Pfizer Inc. PFE
28.67
0.26
0.92%
as of 25 Sep
- Market cap
- $161.7B
- P/E
- 37.7×
Follow PFE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Pfizer Inc. (PFE) Total debt
Pfizer Inc.'s total debt at the end of fiscal 2025 was $64.8B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $63.2B. Over the past ten years it has ranged from $35.8B (fiscal 2022) to $71.9B (fiscal 2023); the current reading is higher than 91% of that period. Pfizer Inc. ranks 2nd of 21 Drug Manufacturers General companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $64.8B | 0.69% |
| FY2024 | $64.4B | (10.48%) |
| FY2023 | $71.9B | 100.64% |
| FY2022 | $35.8B | (6.78%) |
| FY2021 | $38.4B | (3.51%) |
| FY2020 | $39.8B | (23.61%) |
| FY2019 | $52.2B | 24.94% |
| FY2018 | $41.7B | (4.03%) |
| FY2017 | $43.5B | 3.34% |
| FY2016 | $42.1B | 8.19% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $63.2B | (1.96%) |
| Mar 2026 | $64.5B | (0.52%) |
| Dec 2025 | $64.8B | 5.00% |
| Sep 2025 | $61.7B | (0.14%) |
| 42 more quarters | Free account |
Against its own ten years
Low $35.8B
High $71.9B
Ten-year median
$42.1B
Current reading's percentile
91
Total debt against peers
| Company | Total debt |
|---|---|
| PFE Pfizer Inc. | $63.2B |
| AMGN Amgen Inc. compare | $57.3B |
| NVS Novartis AG compare | $47.1B |
| BMY Bristol Myers Squibb Company compare | $43.1B |
| AZN AstraZeneca PLC compare | $29.5B |
| GILD Gilead Sciences, Inc. compare | $26.2B |
| SNY Sanofi compare | $25.2B |
| GSK GSK PLC Sponsored ADR compare | $24.5B |
| NVO Novo Nordisk A/S compare | $21.8B |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on PFE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement